Wanchoo departs Agfa for GE's PACS divisionGE Medical Systems late last month again demonstrated its commitment to PACS by luring digital image management veteran Vishal Wanchoo away from his position as vice president of marketing for Agfa
GE Medical Systems late last month again demonstrated its commitment to PACS by luring digital image management veteran Vishal Wanchoo away from his position as vice president of marketing for Agfa Medical. Although GEMS declined official comment, sources close to the Milwaukee company say that Wanchoo has been named general manager of GE's Integrated Imaging Solutions division and will report directly to GEMS president Jeffrey Immelt.
Anthony Lombardo, global general manager of IIS, will also shift positions. He reportedly has been tapped as general manager of IIS Americas sales and reports to Paul Mirabella, GE's vice president and general manager, Americas sales division.
Agfa has not yet named a replacement for Wanchoo, whose last day at the company was Nov. 21. In the meantime, senior marketing manager Bob Cooke will assume some of Wanchoo's responsibilities, with the rest divided among the Impax team at Agfa.
The loss of Wanchoo, who has assumed various roles in Agfa's PACS division since the early '90s, will surely be felt. He has been widely credited as one of the key architects in developing Agfa's strong market position.
The hiring of Wanchoo is a coup for GEMS, which has devoted substantial resources to its IIS division this year, especially with the acquisition of Lockheed Martin Medical Imaging Systems (PNN 5/97). Wanchoo's extensive marketing and engineering experience in PACS should prove invaluable to GEMS as it looks to grow its market share.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.